Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR THERAPY IN PATIENTS WITH ARRHYTHMOGENIC RIGHT-VENTRICULAR CARDIOMYOPATHY, LONG QT SYNDROME, OR NO STRUCTURAL HEART-DISEASE
Autore:
BREITHARDT G; WICHTER T; HAVERKAMP W; BORGGREFE M; BLOCK M; HAMMEL D; SCHELD HH;
Indirizzi:
UNIV MUNSTER,MED KLIN & POLIKLIN,ALBERT SCHWEITZER STR 33 D-48129 MUNSTER GERMANY UNIV HOSP MUNSTER,DEPT CARDIOL & ANGIOL MUNSTER GERMANY UNIV HOSP MUNSTER,DEPT CARDIOTHORAC SURG MUNSTER GERMANY
Titolo Testata:
The American heart journal
fascicolo: 4, volume: 127, anno: 1994,
parte:, 2 supplemento:, S
pagine: 1151 - 1158
SICI:
0002-8703(1994)127:4<1151:ICTIPW>2.0.ZU;2-Q
Fonte:
ISI
Lingua:
ENG
Soggetto:
TERM FOLLOW-UP; SUDDEN-DEATH; TACHYCARDIA; DYSPLASIA; FIBRILLATION; PROGNOSIS;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Citazioni:
29
Recensione:
Indirizzi per estratti:
Citazione:
G. Breithardt et al., "IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR THERAPY IN PATIENTS WITH ARRHYTHMOGENIC RIGHT-VENTRICULAR CARDIOMYOPATHY, LONG QT SYNDROME, OR NO STRUCTURAL HEART-DISEASE", The American heart journal, 127(4), 1994, pp. 1151-1158

Abstract

Recent technical developments in implantable cardioverter defibrillator (ICD) systems and reduced operative mortality and morbidity rates associated with ICD implantation have expanded the indications for ICD treatment of ventricular tachyarrhythmias. This review summarizes dataregarding ICD therapy in patients with arrhythmogenic right ventricular cardiomyopathy, long CT syndrome, and idiopathic ventricular fibrillation and presents preliminary concepts for identification of patients who will benefit more from ICD therapy than from pharmacologic and other nonpharmacologic approaches. Recent studies suggest that ICD therapy may improve long-term prognosis by reliably terminating recurrences of life-threatening arrhythmias. Appropriate ICD therapies during mean follow-up periods of 12 to 36 months occurred in 30% of patients with idiopathic ventricular fibrillation to 50% of patients with arrhythmogenic right ventricular cardiomyopathy and long QT syndrome. At present no strict recommendations can be given for ICD implantation in these patients. However, at least in cardiac arrest survivors in whom theclinical arrhythmia is not reproducibly inducible during electrophysiologic study, ICD therapy appears to be superior to other treatment options with regard to long-term survival and thus should be considered as a first-line treatment. We are hopeful that continued study of long-term follow-up with and without ICD treatment and improved risk stratification will lead to better criteria for selection of treatment options.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 12/07/20 alle ore 09:14:02